Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Growth Through 2030 Creates New Strategic Opportunities
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The market for raw materials used in messenger ribonucleic acid (mRNA) synthesis has experienced consistent growth over the recent past. Starting at $3.03 billion in 2025, it is projected to reach $3.12 billion by 2026, reflecting a compound annual growth rate (CAGR) of 3.0%. This historical expansion has been driven by factors such as an increasing need for vaccines, advancements in molecular biology, heightened research and development spending in synthetic biology, a surge in infectious disease outbreaks, and the creation of more effective transcription enzymes.
The market for raw materials used in messenger ribonucleic acid (mRNA) synthesis is projected to experience consistent expansion in the coming years. By 2030, its value is anticipated to reach $3.65 billion, driven by a compound annual growth rate (CAGR) of 4.0%. This forecasted growth is influenced by factors such as the expansion of mRNA-based therapeutics, the rising adoption of automated platforms for mRNA synthesis, increased efforts in personalized medicine, the establishment of biotechnology manufacturing hubs, and ongoing innovations in nucleotide modifications. Key trends shaping the future include the optimization of synthetic mRNA, the development of high-purity raw materials, scalable in-vitro transcription methods, standardization of supply chains for mRNA production, and rigorous quality control alongside regulatory compliance.
Download A Free Sample Report For Comprehensive Market Insights:
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Growth Drivers And Industry Catalysts
The rising prevalence of cancer and chronic conditions is anticipated to accelerate expansion in the mRNA synthesis raw materials market. Cancer is characterized by the uncontrolled growth of abnormal cells, which can invade nearby tissues and potentially spread to other parts of the body through the bloodstream and lymphatic system. Chronic diseases are generally defined as health issues that last for a year or longer, require continuous medical attention, hinder daily activities, or combine these factors. Raw materials for mRNA synthesis are employed in drug discovery, vaccine creation, and the production of RNA-based therapeutics to achieve superior immunogenicity, greater effectiveness, and quicker manufacturing timelines, all of which are applicable in addressing cancer and chronic disorders. As an example, in January 2024, data from the American Cancer Society, a non-profit organization based in the United States, indicated that the country is expected to face 2,001,140 new cancer diagnoses and 611,720 cancer-related deaths in 2024, compared to 1,958,310 cases and 609,820 deaths in 2023. Additionally, in September 2025, the British Heart Foundation, a UK-based charity, reported that across the United Kingdom, more than 7.6 million people—including over 4 million men and more than 3.6 million women—are living with cardiovascular disease. Projections suggest that, fueled by an aging population and improved survival rates, this number could increase by approximately 1 million by 2030 and by around 2 million by 2040. Consequently, the growing frequency of cancer and chronic illnesses serves as a key driver for the mRNA synthesis raw materials market.
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Segment Analysis: What Are The Major Market Categories?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Trends Influencing Long-Term Demand
Major players in the messenger ribonucleic acid (mRNA) synthesis raw materials market are increasingly prioritizing strategic collaborations to strengthen their technological expertise, broaden their range of high-quality raw materials, and speed up the development of next-generation mRNA treatments. These strategic collaborations are defined as formal alliances formed among biotech companies, enzyme developers, and nucleic acid technology suppliers to jointly create advanced IVT enzymes, modified nucleotides, capping analogs, or other essential components intended to boost mRNA yield, purity, stability, and safety. As a case in point, in September 2024, TriLink Biotechnologies, a US biotechnology firm, entered into a partnership with Alphazyme LLC, a US-based firm specializing in custom molecular biology enzymes, to introduce the CleanScribe RNA Polymerase. This next-generation IVT enzyme is capable of cutting double-stranded RNA formation by as much as 85% during mRNA production, thus facilitating the creation of safer and more effective mRNA-based therapies.
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Leading Companies Driving Competitive Growth
Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Access The Complete Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report:
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the mRNA synthesis raw materials market in 2025. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
